Iterum Therapeutics plc (ITRMF)
↓ Download CSV- Sector Manufacturing
- Incorporated L2
- Fiscal year ends Dec 31
| Metric (FY) | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | — | — | — | $0 | $0 | $37.0K | $869.0K | $508.0K | $0 | — |
| Operating Income | -$18.70M | -$47.47M | -$30.38M | -$24.54M | -$32.13M | -$102.02M | -$76.56M | -$29.45M | -$13.36M | — |
| Net Income | -$24.77M | -$38.37M | -$44.43M | -$91.56M | -$52.01M | -$103.13M | -$77.06M | -$29.41M | -$13.46M | — |
| EPS (Diluted) | $-1.26 | $-2.96 | $-3.63 | $-8.41 | $-32.49 | — | — | — | — | — |
| Total Assets | $44.59M | $26.26M | $66.83M | $91.51M | $32.79M | $25.75M | $97.87M | $46.76M | — | — |
| Total Liabilities | $48.68M | $32.66M | $38.83M | $41.27M | $83.35M | $51.99M | $26.25M | $7.21M | — | — |
| Shareholders' Equity | -$4.08M | -$6.40M | $28.00M | $50.23M | -$50.56M | -$26.24M | $71.62M | $39.49M | $22.67M | $14.95M |
| Cash & Equivalents | $24.12M | $6.07M | $21.09M | $27.45M | $14.51M | $4.80M | $44.55M | $8.48M | — | — |
| Operating Cash Flow | -$26.77M | -$39.33M | -$18.47M | -$15.84M | -$54.53M | -$81.92M | -$77.25M | -$30.60M | -$11.30M | — |
| Capital Expenditures | $2.0K | $13.0K | $62.0K | $61.0K | $11.0K | $24.0K | $90.0K | $812.0K | — | — |
| Shares Outstanding | 19.70M | 12.96M | 12.24M | 10.89M | 1.60M | — | — | — | — | — |